Business Model in Practice 2: Personalized Medicine

Wednesday, 26 June 2024, 13:45 – 14:45 

Elena Tufan | Director, Head of Site Supply Chain, Kite

Elena Tufan is passionate about bringing innovative therapies to patients around the world. With 13+ years of experience in Supply Chain Management in multiple industries, from consumer electronics & goods to medical devices and pharmaceuticals. The last five years of which being focused on launching Kite’s first two cell therapies in over 22 countries across Europe and the Middle East. Currently, she is Director of Site Supply Chain at Kite’s European cell therapy manufacturing facility in the Netherlands. Elena leads an exceptionally talented multinational team of more than 50 people focused on delivering Kite’s therapies faster, and more efficiently through a global network of manufacturing facilities, to thousands of patients in more than 24 countries worldwide.

Elena is originally from Romania and lives in the Netherlands for 10 years. She holds a bachelor’s degree in computer science and engineering (BEng), a master’s degree in supply chain management (MSc.) from the Politehnica University of Bucharest, and a Professional Doctorate in Industrial Engineering (PDEng.) from the Eindhoven University of Technology.

Kite

Kite, a Gilead Science company, is a global leader in cell therapy. Founded in 2009, and headquartered in US, the company has three manufacturing facilities globally. Their European production site is located in Hoofddorp, near Schiphol airport. 

Kite is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. It has a singular focus on cell therapy, an innovative, individualized treatment for people with certain types of blood cancer.

Business Model in Practice 2: Personalized Medicine

Hear directly from the pioneer in cell therapy about the advances and unique challenges in manufacturing and supply of approved cell therapies which are individualized treatments for certain types of blood cancer. You will be provided with the insights about the flexible solutions that employ autologous approaches to manufacture and supply in unique decentralized supply chains. But what does it take to operate in such an environment? In this session, you will also learn about the multicultural environment and organizational culture which make Kite a success story.